Editorial Board of CML Lung Cancer

Editorial Board

Editorial Advisory Board

William Cho
Scientific Officer (Oncology), Hospital Authority,
Hong Kong, SAR People's Republic of China

Cesare Gridelli
Director, Department of Oncology/Hematology, and Head, Division of Medical Oncology,
SG Moscati Hospital, Avellino, Italy

Primo N Lara, Jr
Professor of Medicine and Director, Clinical Trials Support Unit,
University of California, Sacramento, CA, USA

Egbert F Smit
Professor of Pulmonary Medicine,
Vrije Universiteit Medical Centre, Amsterdam, The Netherlands


Johan Vansteenkiste
Professor of Thoracic Oncology,
University Hospital Gasthuisberg, Leuven, Belgium

Clinical Editors

Richard Booton
Consultant Repiratory Physician,
University Hospital of South Manchester, Manchester, UK

Balazs Halmos
Chief, Section of Thoracic Oncology,
Columbia University Medical Center, New York, NY, USA

Philip Linden
Chief, Division of Thoracic Surgery,
Case Medical Center, Cleveland, OH, USA

READER POLL

Lung Cancer poll 1
When treating advanced, partially resectable large cell neuroendocrine carcinomas of the lung, would you initially treat with:






Powered by NetPolls

SUBMIT AN ARTICLE